Connection

MICHAEL MANCINI to HeLa Cells

This is a "connection" page, showing publications MICHAEL MANCINI has written about HeLa Cells.
Connection Strength

1.430
  1. A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic Chemicals. SLAS Discov. 2020 08; 25(7):695-708.
    View in: PubMed
    Score: 0.145
  2. Characterizing properties of non-estrogenic substituted bisphenol analogs using high throughput microscopy and image analysis. PLoS One. 2017; 12(7):e0180141.
    View in: PubMed
    Score: 0.119
  3. Use of HCA in subproteome-immunization and screening of hybridoma supernatants to define distinct antibody binding patterns. Methods. 2016 Mar 01; 96:75-84.
    View in: PubMed
    Score: 0.106
  4. Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays. Chem Biol. 2014 Jun 19; 21(6):743-53.
    View in: PubMed
    Score: 0.096
  5. Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses. Nucleic Acids Res. 2013 Apr; 41(7):4036-48.
    View in: PubMed
    Score: 0.088
  6. Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis. J Cell Biol. 2011 Jan 10; 192(1):55-67.
    View in: PubMed
    Score: 0.076
  7. Automated microscopy and image analysis for androgen receptor function. Methods Mol Biol. 2011; 776:313-31.
    View in: PubMed
    Score: 0.076
  8. Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects. PLoS One. 2008; 3(11):e3605.
    View in: PubMed
    Score: 0.065
  9. Activation of estrogen receptor-alpha by E2 or EGF induces temporally distinct patterns of large-scale chromatin modification and mRNA transcription. PLoS One. 2008 May 28; 3(5):e2286.
    View in: PubMed
    Score: 0.063
  10. Estrogen-receptor-alpha exchange and chromatin dynamics are ligand- and domain-dependent. J Cell Sci. 2006 Oct 01; 119(Pt 19):4101-16.
    View in: PubMed
    Score: 0.056
  11. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. J Cell Biochem. 2006 Jul 01; 98(4):770-88.
    View in: PubMed
    Score: 0.055
  12. High-resolution, high-throughput microscopy analyses of nuclear receptor and coregulator function. Methods Enzymol. 2006; 414:188-210.
    View in: PubMed
    Score: 0.053
  13. Inactivating Pit-1 mutations alter subnuclear dynamics suggesting a protein misfolding and nuclear stress response. J Cell Biochem. 2004 Jul 01; 92(4):664-78.
    View in: PubMed
    Score: 0.048
  14. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat Cell Biol. 2002 Oct; 4(10):806-10.
    View in: PubMed
    Score: 0.043
  15. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol. 2001 Jan; 3(1):15-23.
    View in: PubMed
    Score: 0.038
  16. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol Endocrinol. 2000 Apr; 14(4):518-34.
    View in: PubMed
    Score: 0.036
  17. Measuring Mobility in Chromatin by Intensity-Sorted FCS. Biophys J. 2019 03 19; 116(6):987-999.
    View in: PubMed
    Score: 0.033
  18. Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK. Mol Endocrinol. 2016 Feb; 30(2):158-72.
    View in: PubMed
    Score: 0.027
  19. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death. Cancer Cell. 2015 Aug 10; 28(2):240-52.
    View in: PubMed
    Score: 0.026
  20. Differential phosphorylation of perilipin 1A at the initiation of lipolysis revealed by novel monoclonal antibodies and high content analysis. PLoS One. 2013; 8(2):e55511.
    View in: PubMed
    Score: 0.022
  21. Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine. Adv Exp Med Biol. 2011; 707:63-5.
    View in: PubMed
    Score: 0.019
  22. Ligand-induced large-scale chromatin dynamics as a biosensor for the detection of estrogen receptor subtype selective ligands. Gene. 2010 Jun 15; 458(1-2):37-44.
    View in: PubMed
    Score: 0.018
  23. Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancer. Cancer Res. 2010 Jan 15; 70(2):842-51.
    View in: PubMed
    Score: 0.018
  24. Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine. PLoS One. 2009 Dec 09; 4(12):e8179.
    View in: PubMed
    Score: 0.018
  25. Aurora-C kinase supports mitotic progression in the absence of Aurora-B. Cell Cycle. 2009 Sep 15; 8(18):2984-94.
    View in: PubMed
    Score: 0.017
  26. Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1. Mol Endocrinol. 2009 Sep; 23(9):1335-45.
    View in: PubMed
    Score: 0.017
  27. Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305. Breast Cancer Res Treat. 2010 Jan; 119(1):71-85.
    View in: PubMed
    Score: 0.017
  28. Plasma membrane assays and three-compartment image cytometry for high content screening. Assay Drug Dev Technol. 2007 Feb; 5(1):29-48.
    View in: PubMed
    Score: 0.014
  29. Reduced intranuclear mobility of APL fusion proteins accompanies their mislocalization and results in sequestration and decreased mobility of retinoid X receptor alpha. Mol Cell Biol. 2004 May; 24(10):4465-75.
    View in: PubMed
    Score: 0.012
  30. The dynamic mobility of histone H1 is regulated by cyclin/CDK phosphorylation. Mol Cell Biol. 2003 Dec; 23(23):8626-36.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.